Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
12.31
+0.07 (0.57%)
Aug 14, 2025, 11:35 AM - Market open
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $1.75 billion as of August 14, 2025. Its market cap has decreased by -58.77% in one year.
Market Cap
1.75B
Enterprise Value
1.18B
1-Year Change
-58.77%
Ranking
Category
Stock Price
$12.31
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $1.75B, an increase of 121.43%. That is a compound annual growth rate of 17.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.74B | -27.37% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |